Skip to main content
Access Bio, Inc. logo

Access Bio, Inc. — Investor Relations & Filings

Ticker · 950130 ISIN · KR8840090003 LEI · 335800Q5TV77F4L9Q648 KO Manufacturing
Open in API
Filings indexed 248 across all filing types
Latest filing 2023-03-28 Board/Management Inform…
Country IN India
Listing KO 950130

About Access Bio, Inc.

https://accessbio.net/

Access Bio, Inc. is a company dedicated to the prevention and early diagnosis of infectious diseases through the research, development, and manufacturing of in vitro diagnostic solutions. Its portfolio includes rapid diagnostic tests (RDTs), immunochemical diagnostics, biosensors, and molecular diagnostic products. The company is recognized for commercializing high-quality tests to combat significant global health threats, including malaria, COVID-19, HIV, and HPV. With a large-scale manufacturing capacity, Access Bio distributes its products globally, serving as a key partner in global health, particularly in the fight against often-neglected diseases.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of an outside director (사외이사). This type of corporate governance disclosure specifically pertains to changes in the board of directors, which falls under the 'Board/Management Information' category.
2023-03-28 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by shareholders or management to solicit proxies for an upcoming general meeting. This falls under the category of Proxy Solicitation & Information Statement (PSI).
2023-03-22 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean Exchange (KRX). It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is specifically the regulatory filing of the audit report itself, which falls under the 'Audit Report / Information' category. FY 2022
2023-03-20 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for Access Bio, Inc. for the fiscal year 2022 (Jan 1, 2022 to Dec 31, 2022). It contains comprehensive financial statements, management discussion and analysis, audit information, and corporate governance details. This is a standard annual regulatory filing required by the Korean Financial Services Commission and Korea Exchange, which corresponds to the 10-K category in the provided schema. FY 2022
2023-03-20 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by Access Bio. It details the contract amount, product type (COVID-19 test kits), and the date of the contract. Since this is a specific regulatory announcement of a material business event (a supply contract) that does not fit into categories like financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2023-03-15 Korean
전환가액의조정(제5회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Access Bio regarding the adjustment of the conversion price for its 5th series convertible bonds due to a decline in market price. This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the 'Capital/Financing Update' category as it directly relates to the company's financing activities and capital structure adjustments.
2023-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.